Publikationen von M. Zweckstetter

Zeitschriftenartikel (249)

241.
Zeitschriftenartikel
Zweckstetter, M.; Bax, A.: Single-step determination of protein substructures using dipolar couplings: Aid to structural genomics. Journal of the American Chemical Society 123 (38), S. 9490 - 9491 (2001)
242.
Zeitschriftenartikel
Zweckstetter, M.; Bax, A.: Prediction of sterically induced alignment in a dilute liquid crystalline phase: Aid to protein structure determination by NMR. Journal of the American ChemicaL Society 122 (15), S. 3791 - 3792 (2000)
243.
Zeitschriftenartikel
Zweckstetter, M.; Holak, T. A.: Robust refocusing of 13C magnetization in multidimensional NMR experiments by adiabatic fast passage pulses. Journal of Biomolecular NMR 15 (4), S. 331 - 334 (1999)
244.
Zeitschriftenartikel
Pfänder, R.; Neumann, L.; Zweckstetter, M.; Seger, C.; Holak, T. A.; Tampé, R.: Structure of the active domain of the herpes simplex virus protein ICP47 in water/sodium dodecyl sulfate solution determined by nuclear magnetic resonance spectroscopy. Biochemistry 38 (41), S. 13692 - 13698 (1999)
245.
Zeitschriftenartikel
Kalus, W.; Zweckstetter, M.; Renner, C.; Sanchez, Y.; Georgescu, J.; Grol, M.; Demuth, D.; Schumacher, R.; Dony, C.; Lang, K. et al.; Holak, T. A.: Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): Implications for IGF and IGF-I receptor interactions. EMBO Journal 17 (22), S. 6558 - 6572 (1998)
246.
Zeitschriftenartikel
Mühlhahn, P.; Zweckstetter, M.; Georgescu, J.; Ciosto, C.; Renner, C.; Lanzendörfer, M.; Lang, K.; Ambrosius, D.; Baier, M.; Kurth, R. et al.; Holak, T. A.: Structure of interleukin 16 resembles a PDZ domain with an occluded peptide binding site. Nature Structural and Molecular Biology 5, S. 682 - 686 (1998)
247.
Zeitschriftenartikel
Zweckstetter, M.; Holak, T. A.: An adiabatic multiple spin-echo pulse sequence: removal of systematic errors due to pulse imperfections and off-resonance effects. Journal of Magnetic Resonance 133 (1), S. 134 - 147 (1998)
248.
Zeitschriftenartikel
Kohfeldt, E.; Göhring, W.; Mayer, U.; Zweckstetter, M.; Holak, T. A.; Chu, M. L.; Timp, R.: Conversion of the Kunitz-type module of collagen VI into a highly active trypsin inhibitor by site-directed mutagenesis. FEBS Journal 238 (2), S. 333 - 340 (1996)
249.
Zeitschriftenartikel
Zweckstetter, M.; Czisch, M.; Mayer, U.; Chu, M. L.; Zinth, W.; Timpl, R.; Holak, T. A.: Structure and multiple conformations of the Kunitz-type domain from human type VI collagen alpha3(VI) chain in solution. Structure 4 (2), S. 195 - 209 (1996)

Konferenzbeitrag (7)

250.
Konferenzbeitrag
Oroz, J.; Chang, B. J.; Wysoczanski, P.; Lee, C. T.; Perez-Lara, A.; Chakraborty, P.; Hofele, R. V.; Baker, J. D.; Blair, L. J.; Biernat, J. et al.; Urlaub, H.; Mandelkow, E.; Dickey, C. A.; Zweckstetter, M.: Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex. 71st Annual Meeting of the American-Academy-of-Neurology (AAN), Philadelphia, PA, 04. Mai 2019 - 10. Mai 2019. Neurology 92 (Suppl), P1.1-006, (2019)
251.
Konferenzbeitrag
Robustelli, P.; Piana-Agostinetti, S.; Ibanez de Opakua, A.; Giordanetto, F.; Campbell-Bezat, C. K.; Becker, S.; Pan, A. C.; Zweckstetter, M.; Shaw, D. E.: Improved physical models enable the investigation of molecular recognition in intrinsically disordered proteins at atomistic rsolution. 63rd Annual Meeting of the Biophysical-Society, Baltimore, MD, 02. März 2019 - 06. März 2019. Biophysical Journal 116 (Suppl_1), S. 303A - 303A (2019)
252.
Konferenzbeitrag
Rauscher, S.; Gapsys, V.; Zhou, M.; Van, Q.; Gajda, M. J.; Zweckstetter, M.; Enderlein, J.; de Groot, B. L.; Grubmüller, H.: Structural ensembles of intrinsically disordered proteins depend strongly on force field: A comparison to experiment. 60th Annual Meeting of the Biophysical-Society, Los Angeles, CA, 27. Februar 2016 - 02. März 2016. Biophysical Journal 110 (Suppl 1), 3 Aufl., S. 358A - 358A (2016)
253.
Konferenzbeitrag
Zweckstetter, M.: Intrinsically disordered proteins in neurodegeneration. 60th Annual Meeting of the Biophysical-Society, Los Angeles, CA, 27. Februar 2016 - 02. März 2016. Biophysical Journal 110 (Suppl 1), 3 Aufl., S. 2a - 2a (2016)
254.
Konferenzbeitrag
Levin, J.; Wagner, J.; Ryazanov, S.; Leonov, A.; Shi, S.; Schmidt, F.; Prix, C.; Bertsch, U.; Mitteregger-Kretzschmar, G.; Geissen, M. et al.; Hischberger, T.; Tavan, P.; Pilger, J.; Zweckstetter, M.; Frank, T.; Baehr, M.; Weishaupt, J.; Uhr, M.; Urlaub, H.; Teichmann, U.; Boetzel, K.; Groschup, M.; Kretzschmar, H. A.; Griesinger, C.; Giese, A.: Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor. 15th International Congress of Parkinsons Disease and Movement Disorders, Toronto, CANADA, 2011. Movement Disorders 26 (Supplement 2), S. S21 - S21 (2011)
255.
Konferenzbeitrag
Montaville, P.; Kim, H. Y.; Vijayan, V.; Becker, S.; Zweckstetter, M.: H-1, N-15, and C-13 resonance assignment of the C2A domain of rabphilin3A. Journal of Biomolecular NMR 36 (Suppl. 1), S. 20 - 20 (2006)
256.
Konferenzbeitrag
Bertoncini, C. W.; Cherny, D. I.; Fernandez, C. O.; Garfinkel, E.; Griesinger, C.; Hoyer, W.; Jares-Erijman, E. A.; Jovin, T. M.; Marsh, D.; Rasia, R. M. et al.; Roberti, M. J.; Subramaniam, V.; Zweckstetter, M.: 3D structure, ligand binding, autoinhibition, aggregation, and cellular distribution of wild-type, mutant, and labeled alpha-synuclein. Biophysical Journal 88 (1), S. 396A - 396A (2005)

Meeting Abstract (1)

257.
Meeting Abstract
Villinger, S.; Briones, R.; Giller, K.; Zachariae, U.; Lange, A.; de Groot, B. L.; Griesinger, C.; Becker, S.; Zweckstetter, M.: Functional dynamics in the voltage-dependent anion channel. In FEBS Journal, 279 (Suppl. 1), P20-86, S. 433 - 433. 22nd IUBMB Congress/37th FEBS Congress, Seville/Spain, 04. September 2012 - 09. September 2012. (2012)

Patent (1)

258.
Patent
Zweckstetter, M.; Karpinar, P.; Griesinger, C.: Mutant alpha-synuclein with increased toxicity. WO/2010/015714 (2010)
Zur Redakteursansicht